Average Co-Inventor Count = 1.85
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Lixte Biotechnology, Inc. (26 from 27 patents)
2. Other (3 from 832,843 patents)
3. The United States of America, As Represented by the Secretary, Department of Health and Human Services (1 from 3,539 patents)
4. Institut National De La Sante Et De La Recherche Medicale (1 from 1,743 patents)
5. H. Lee Moffitt Cancer Center and Research Institute, Inc. (290 patents)
30 patents:
1. 12343342 - Methods for treating soft tissue sarcoma
2. 12168008 - Oxabicycloheptanes for modulation of immune response
3. 11931354 - Formulations of oxabicycloheptanes and oxabicycloheptenes
4. 11866444 - Oxabicycloheptane prodrugs
5. 11236102 - Oxabicycloheptane prodrugs
6. 10668062 - Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes
7. 10618908 - Oxabicycloheptane prodrugs
8. 10532050 - Formulations of oxabicycloheptanes and oxabicycloheptenes
9. 10434100 - Protein phosphatase 2A inhibitors for treating myelodysplastic syndromes
10. 10413541 - Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders
11. 10399993 - Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
12. 10364252 - Oxabicycloheptane prodrugs
13. 10149847 - Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes
14. 10071094 - Protein phosphatase 2A inhibitors for treating myelodysplastic syndromes
15. 10023587 - Oxabicycloheptanes and oxabicycloheptenes, their preparation and use